UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

Ophthalmology (Rochester, Minn.), 2015-02, Vol.122 (2), p.302-307

2015

Volltextzugriff (PDF)

Efficacy of trabecular bypass stent through 2 years: Data from the United States pivotal trial

Journal of cataract and refractive surgery, 2014-08, Vol.40 (8), p.1325-1326

Bacharach, Jason, MD

2014

Volltextzugriff (PDF)

Early diagnostics and interventional glaucoma

Therapeutic advances in ophthalmology, 2024-01, Vol.16, p.25158414241287431

2024

Volltextzugriff (PDF)

Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension

Ophthalmology and therapy, 2024-09, Vol.13 (9), p.2357-2367

2024

Volltextzugriff (PDF)

Upneeq for the treatment of speculum-induced blepharoptosis

JCRS online case reports, 2021-04, Vol.9 (2), p.e00048

2021

Volltextzugriff (PDF)

Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysis

Journal of cataract and refractive surgery, 2021-01, Vol.47 (1), p.53-64

2021

Volltextzugriff (PDF)

A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options

Eye (London), 2021-09, Vol.35 (9), p.2468-2481

2021

Volltextzugriff (PDF)

Impact of Dry Eye Disease on Work Productivity, and Patients' Satisfaction With Over-the-Counter Dry Eye Treatments

Investigative ophthalmology & visual science, 2016-06, Vol.57 (7), p.2975-2982

2016

Volltextzugriff (PDF)

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

Advances in therapy, 2020-04, Vol.37 (4), p.1620-1631

2020

Volltextzugriff (PDF)

Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension

American journal of ophthalmology, 2011-11, Vol.152 (5), p.834-841.e1

2011

Volltextzugriff (PDF)

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

American journal of ophthalmology, 2024-07, Vol.263, p.23-34

2024

Volltextzugriff (PDF)

Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study

Eye & contact lens, 2020-01, Vol.46 Suppl 1 (1), p.S14-S19

2020

Volltextzugriff (PDF)

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

American journal of ophthalmology, 2019-08, Vol.204, p.97-104

2019

Volltextzugriff (PDF)

Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension

British journal of ophthalmology, 2016-03, Vol.100 (3), p.339-344

2016

Volltextzugriff (PDF)

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.119-126

2020

Volltextzugriff (PDF)

24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2

Ophthalmology (Rochester, Minn.), 2019-08, Vol.126 (8), p.1095-1104

2019

Volltextzugriff (PDF)

Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension

Drugs (New York, N.Y.), 2024-01, Vol.84 (1), p.83-97

2024

Volltextzugriff (PDF)

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies

Cornea, 2019-10, Vol.38 (10), p.1259-1265

2019

Volltextzugriff (PDF)

24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial

Ophthalmology (Rochester, Minn.), 2019-08, Vol.126 (8), p.1095-1104

2019

Volltextzugriff (PDF)

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Drugs (New York, N.Y.), 2021-11, Vol.81 (17), p.2017-2033

2021

Volltextzugriff (PDF)

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial [Corrigendum]

Clinical ophthalmology (Auckland, N.Z.), 2023-09, Vol.17, p.2763-2764

2023

Volltextzugriff (PDF)

Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies

Journal of ocular pharmacology and therapeutics, 2023-02, Vol.39 (1), p.55-62

2023

Volltextzugriff (PDF)

Negative Pressure Application via a Multi-Pressure Dial to Lower IOP in Patients with Suspected Glaucoma or Open Angle Glaucoma

Journal of glaucoma, 2023-08, Vol.32 (8), p.708-720

2023

Volltextzugriff (PDF)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Clinical ophthalmology (Auckland, N.Z.), 2018-01, Vol.12, p.1921-1929

2018

Volltextzugriff (PDF)

Topical Review: An Update of Diagnostic and Management Algorithms for Acquired Blepharoptosis

Optometry and vision science, 2022-03, Vol.99 (3), p.230-240

2022

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Ophthalmology
(43)
Humans
(35)
Female
(25)
Male
(25)
Aged
(23)
Middle Aged
(22)
Glaucoma
(19)
Adult
(18)
Double-Blind Method
(17)
Glaucoma, Open-Angle - Drug Therapy
(17)
Aged, 80 And Over
(16)
Ocular Hypertension - Drug Therapy
(16)
Intraocular Pressure - Drug Effects
(15)
Treatment Outcome
(15)
Intraocular Pressure
(14)
Antihypertensive Agents - Therapeutic Use
(12)
Tonometry, Ocular
(12)
Patients
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

Efficacy of trabecular bypass stent through 2 years: Data from the United States pivotal trial

Early diagnostics and interventional glaucoma

Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension

Upneeq for the treatment of speculum-induced blepharoptosis

Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysis

A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options

Impact of Dry Eye Disease on Work Productivity, and Patients' Satisfaction With Over-the-Counter Dry Eye Treatments

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2

Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies

24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial [Corrigendum]

Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies

Negative Pressure Application via a Multi-Pressure Dial to Lower IOP in Patients with Suspected Glaucoma or Open Angle Glaucoma

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Topical Review: An Update of Diagnostic and Management Algorithms for Acquired Blepharoptosis

Suchergebnisse filtern